Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-264379
Filing Date
2024-11-22
Accepted
2024-11-22 16:41:50
Documents
2
Group Members
CHEN YUTCG CROSSOVER FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G d845832dsc13g.htm SC 13G 71940
2 EX-99.1 d845832dex991.htm EX-99.1 4634
  Complete submission text file 0001193125-24-264379.txt   78290
Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036 929-999-4055
Dianthus Therapeutics, Inc. /DE/ (Subject) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90538 | Film No.: 241490450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 705 HIGH STREET PALO ALTO CA 94301
Business Address 705 HIGH STREET PALO ALTO CA 94301 650-924-9424
TCG Crossover GP II, LLC (Filed by) CIK: 0001969280 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G